Aligos Therapeutics presented promising data from five studies at The Liver Meeting® 2026, highlighting their advances in treatments for chronic hepatitis B virus (HBV) infection. Key findings include pevifoscorvir sodium's ability to reduce inflammatory cytokines linked to disease progression and inhibit viral DNA forms associated with HBV integration, potentially lowering risks of liver damage and cancer. Additionally, ALG-170675, a next-generation antisense oligonucleotide, showed superior preclinical efficacy, supporting its potential as a best-in-class therapy. These results reinforce Aligos' strategy to develop innovative therapies to improve outcomes for liver disease patients, with ongoing clinical trials and further research planned.
Aligos Therapeutics' presentation of positive data at The Liver Meeting® 2026 is the subject, with Pluang's Health-sector market snapshot as of Nov 06, 2026 04:11 WIB: out of 150 priced US Health stocks, 16 rose and 134 fell. Notable movers include Natera Inc. (NTRA) at USD 299.83 with a 1-day change of -23.32% and a typical hold time of 14 days, Guardant Health Inc. (GH) at USD 129.81 down 23.00%, and Inovio Pharmaceuticals Inc. (INO) at USD 1.26 down 22.22%.
Autoscope Technologies Corporation reported a net income of $366,000 for Q3 2026, a 275% increase from a net loss in the same period last year, driven by higher royalties and lower operating expenses. The company declared a quarterly dividend of $0.1...
TerrAscend reported Q3 2026 net revenue of $68.2 million, up 4.8% year-over-year, with a gross profit margin of 52.3%. The company achieved its 17th consecutive quarter of positive operating cash flow and 13th quarter of positive free cash flow, refl...
Westwood Holdings Group, Inc. reported a net income of $3.1 million for Q3 2026, up from $1.5 million in Q2 but slightly below last year's $3.7 million. The firm launched the Enhanced Power and Infrastructure ETF (PWRX), the first new ETF on the Texa...
Applied Optoelectronics reported a record $269.9 million revenue for Q3 2026, marking its sixth consecutive quarter of growth and a return to GAAP profitability with a net income of $6.3 million. The company is scaling manufacturing for high-demand A...
Karat Packaging reported third quarter 2026 net sales of $134.7 million, up 8.2% from the previous year, driven by volume growth and e-commerce sales rising nearly 38%. However, net income fell to $4.7 million due to higher product costs, shipping ex...
